Costa FF - Search Results

1

Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Mascarenhas Cdo C, Ferreira da Cunha A, Brugnerotto AF, Gambero S, de Almeida MH, Carazzolle MF, Pagnano KB, Traina F, Costa FF, de Souza CA. Mascarenhas Cdo C, et al. Among authors: costa ff. Leuk Lymphoma. 2014 Aug;55(8):1861-9. doi: 10.3109/10428194.2013.855311. Epub 2014 Feb 4. Leuk Lymphoma. 2014. PMID: 24144310

2

N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis.

De Melo MB, Lorand-Metze I, Lima CS, Saad ST, Costa FF. De Melo MB, et al. Among authors: costa ff. Leuk Lymphoma. 1997 Jan;24(3-4):309-17. doi: 10.3109/10428199709039018. Leuk Lymphoma. 1997. PMID: 9156660

3

Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients.

Melo MB, Costa FF, Saad ST, Lorand-Metze I, Bordin S, Ahmad NN. Melo MB, et al. Among authors: costa ff. Leuk Res. 1998 Sep;22(9):787-92. doi: 10.1016/s0145-2126(98)00047-2. Leuk Res. 1998. PMID: 9716009

4

The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia.

Vigorito AC, Lorand-Metze I, Chauffaile ML, Costa FF, Saad ST. Vigorito AC, et al. Among authors: costa ff. Haematologia (Budap). 1998;29(2):123-32. Haematologia (Budap). 1998. PMID: 9728804

5

p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.

Pagnano KB, Vassallo J, Lorand-Metze I, Costa FF, Saad ST. Pagnano KB, et al. Among authors: costa ff. Am J Hematol. 2001 Jun;67(2):84-92. doi: 10.1002/ajh.1084. Am J Hematol. 2001. PMID: 11343379 Free article.

6

BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells.

Traina F, Carvalheira JB, Saad MJ, Costa FF, Saad ST. Traina F, et al. Among authors: costa ff. FEBS Lett. 2003 Jan 30;535(1-3):17-22. doi: 10.1016/s0014-5793(02)03845-0. FEBS Lett. 2003. PMID: 12560071 Free article.

7

A possible role of the P53 gene deletion as a prognostic factor in multiple myeloma.

Ortega MM, Melo MB, De Souza CA, Lorand-Metze I, Costa FF, Lima CS. Ortega MM, et al. Among authors: costa ff. Ann Hematol. 2003 Jul;82(7):405-9. doi: 10.1007/s00277-003-0632-2. Epub 2003 May 29. Ann Hematol. 2003. PMID: 12783209

8

Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia.

Lourenco GJ, Ortega MM, Nascimento H, Teori MT, De Souza CA, Costa FF, Lima CS. Lourenco GJ, et al. Among authors: costa ff. Eur J Haematol. 2005 Dec;75(6):530-1. doi: 10.1111/j.1600-0609.2005.00567.x. Eur J Haematol. 2005. PMID: 16313269 No abstract available.

9

N-RAS and K-RAS gene mutations in Brazilian patients with multiple myeloma.

Ortega MM, Faria RM, Shitara ES, Assis AM, Albuquerque DM, Oliveira JS, Noguti MA, Faria JR, Costa FF, Lima CS. Ortega MM, et al. Among authors: costa ff. Leuk Lymphoma. 2006 Feb;47(2):285-9. doi: 10.1080/10428190500300969. Leuk Lymphoma. 2006. PMID: 16321859

10

High expression of FMNL1 protein in T non-Hodgkin's lymphomas.

Favaro PM, Traina F, Vassallo J, Brousset P, Delsol G, Costa FF, Saad ST. Favaro PM, et al. Among authors: costa ff. Leuk Res. 2006 Jun;30(6):735-8. doi: 10.1016/j.leukres.2005.10.003. Epub 2006 Feb 21. Leuk Res. 2006. PMID: 16494944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

613 results

Search Page